AbbVie says FDA approves Skyrizi for ulcerative colitis

by OverviewFX | Jun 19, 2024 | Stocks

AbbVie said that the heavily-advertised drug was now approved for four conditions across different so-called “immune-mediated” inflammatory diseases.

‘Make no mistake: Willie Mays was a baseball god’ — a fan’s appreciation

by OverviewFX | Jun 19, 2024 | Stocks

When it comes to Willie Mays, everyone wants to talk about “The Catch.” But I want to talk about the hit.

Inflation returns to Bank of England’s target for the first time in nearly three years

by OverviewFX | Jun 19, 2024 | Stocks

Inflation in the U.K. returned to the Bank of England’s target for the first time in nearly three years, data that underscores the central bank will soon join other peers in beginning to reduce interest rates.

Why the immigration surge under Biden is saving taxpayers money

by OverviewFX | Jun 18, 2024 | Stocks

A wave of illegal border crossings in recent years has sparked heated debate over U.S. immigration policy, but official estimates suggest the surge in migration over the U.S.-Mexico has done wonders for the federal budget outlook.

Oil prices settle at highest since April on brighter demand prospects

by OverviewFX | Jun 18, 2024 | Stocks

Oil futures on Tuesday notched back-to-back session gains to settle at their highest level in seven weeks, buoyed by upbeat prospects for global crude demand.

This family of four is hoping GoFundMe will save them from eviction — similar fundraisers have increased 40% since the pandemic

by OverviewFX | Jun 18, 2024 | Stocks

Rents aren’t growing as fast as they once were, but they’re stuck at a level where many people can’t afford them.